ACE-CAA is currently available for preorder. A link to the course will be available in March 2025.

After successfully completing this activity, the learner will be able to:

• Assess the current state of his or her knowledge of fundamental and subspecialty anesthesia topics and identify knowledge gaps
• Develop a strategy to address identified gaps using resources provided as references within the program
• Utilize enhanced knowledge in clinical practice to improve patient safety and prevent harm

This activity is intended for anesthesiologists, anesthesiologist assistants, and other members of the anesthesia care team.

REVIEWERS
Katie Monroe, CAA, PhD
Decatur, Georgia

Deborah A. Rusy, MD, MBA, FASA
Madison, Wisconsin

Megan L. Varellas, CAA
Asheville, North Carolina

Stacie Wong, MD
Vidalia, Georgia

ASA Staff: Ginger Clark, Managing Editor

Thank you to the editors and contributors for the original ACE program, without whom ACE-CAA would not be possible:

Bhargavi Gali, MD, MHA, ACE Co-Editor-in-Chief
Rochester, Minnesota

Joel O. Johnson, MD, PhD, ACE Co-Editor-in-Chief
Madison, Wisconsin

Stacy L. Jones, MD, MHA, FASA, ACE Co-Editor-in-Chief
Little Rock, Arkansas

Anuj K. Aggarwal, MD
Stanford, California

Shamsuddin Akhtar, MD
New Haven, Connecticut

Vaibhav Bora, MBBS, FASE, FCCM, FCCP
Augusta, Georgia

Kallol Chaudhuri, MD, PhD
Lubbock, Texas

Richard P. Dutton, MD, MBA, FASA
Dallas, Texas

Jennifer M. Hah, MD
Stanford, California

Christopher J. Lace, MD, MBA
Denver, Colorado

Jeffrey Lu, MD
Salt Lake City, Utah

Russell K. McAllister, MD, FASA
Temple, Texas

Shobana Rajan, MD, FASA
Cleveland, Ohio

Sara Robertson, MD, FASA
Madison, Mississippi

Kathryn Rouine-Rapp, MD
San Francisco, California

Ahmed Shalabi, MBBCh, MSc, FCAI
Los Angeles, California

Johannes W. Steyn, MD
Nicholasville, Kentucky

Kofi B. Vandyck, MD
Oklahoma City, Oklahoma

Christine T. Vo, MD, FASA
Oklahoma City, Oklahoma

Maheen A. Wardak, MD
Houston, Texas

ASA remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of ASA to eliminate all situations of potential conflict of interest, but rather to enable those who are working with ASA to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the educational activity course director/chair to ensure that such situations are properly evaluated and, if necessary, resolved. ASA educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all ASA activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.

Ineligible companies are those not eligible to be accredited by the Accreditation Council for Continuing Medical Education because the primary business of these companies is producing, marketing, selling, reselling, or distributing health care products used by or on patients. The faculty and staff below have reported the following financial relationships with ineligible companies:

Ginger Clark
Merck: Stock (self)
Organon & Co: Stock (self)

All disclosed financial relationships have been mitigated. All other faculty, planners, and staff have reported no financial relationships with ineligible companies.

Internet connection and Web browser (Google Chrome, Internet Explorer, Microsoft Edge, Mozilla Firefox, or Safari, updated within the last 3 years). The program may be completed on the ASA My Learning app; however, a computer and Web browser are required for printing a CME certificate.